These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 6209494)
1. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. Unger T; Ganten D; Lang RE; Schölkens BA J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494 [TBL] [Abstract][Full Text] [Related]
2. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. Unger T; Ganten D; Lang RE; Schölkens BA J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498). Unger T; Moursi M; Ganten D; Hermann K; Lang RE J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465 [TBL] [Abstract][Full Text] [Related]
4. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. Unger T; Fleck T; Ganten D; Lang RE; Rettig F Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. Moursi MG; Ganten D; Lang RE; Unger T J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591 [TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)]. Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275 [TBL] [Abstract][Full Text] [Related]
8. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications. Unger T; Ganten D; Lang RE Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288. Gohlke P; Schölkens B; Henning R; Urbach H; Unger T J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S32-6. PubMed ID: 2483426 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). Schölkens BA; Becker RH; Kaiser J Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats. Rowland NE; Fregly MJ Behav Neurosci; 1988 Dec; 102(6):953-60. PubMed ID: 2850816 [TBL] [Abstract][Full Text] [Related]
12. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril]. Clauser E Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594 [TBL] [Abstract][Full Text] [Related]
13. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat. Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747 [TBL] [Abstract][Full Text] [Related]
14. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. Edling O; Bao G; Feelisch M; Unger T; Gohlke P J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation. Wilkes BM J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759 [TBL] [Abstract][Full Text] [Related]
16. Influence of the converting enzyme inhibitors Hoe 498, enalapril and captopril on vascular reactivity of isolated arterial preparations. Schölkens BA; Xiang JZ; Tilly H Clin Exp Hypertens A; 1984; 6(10-11):1807-13. PubMed ID: 6099766 [No Abstract] [Full Text] [Related]
17. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Iyer SN; Ferrario CM; Chappell MC Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570). Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998 [TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man. Malatino LS; Manhem P; Ball SG; Leckie BJ; Morton JJ; Murray GD; Robertson JI J Clin Hypertens; 1986 Sep; 2(3):231-7. PubMed ID: 3023553 [TBL] [Abstract][Full Text] [Related]
20. Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Xiang JZ; Linz W; Becker H; Ganten D; Lang RE; Schölkens B; Unger T Eur J Pharmacol; 1985 Jul; 113(2):215-23. PubMed ID: 2995065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]